Skip to main content

Advertisement

SpringerLink
Log in

Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy

  • Urology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. van Renterghem K, Van Koeveringe G, Achten R, van Kerrebroeck P (2010) A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies. Int Urol Nephrol 42:29–38

    Article  Google Scholar 

  2. Gjertson CK, Albertsen PC (2011) Use and assessment of PSA in prostate cancer. Med Clin North Am 95:191–200

    Article  Google Scholar 

  3. Atan A, Güzel Ö (2013) How should prostate specific antigen be interpreted? Turk J Urol 39:188–193

    Article  Google Scholar 

  4. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC (1998) Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–1547

    Article  CAS  Google Scholar 

  5. Rouviere O, Moldovan PC (2019) The current role of prostate multiparametric magnetic resonance imaging. Asian J Urol 6:137–145

    Article  Google Scholar 

  6. Mottet N, van den Berg RCA, Briers E, Bourke L, Cornford P, De Santis M, et al (2018) EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. EAU Guideline https://uroweb.org/guideline/prostate-cancer/. Accessed 30 Dec 2018

Download references

Funding

The author has declared that this study did not receive any financial support.

Author information

Authors and Affiliations

  1. Department of Urology, School of Medicine, Gazi University, Ankara, Turkey

    Ali Atan

Authors
  1. Ali Atan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Atan.

Ethics declarations

Conflict of interest

No conflict of interest was declared by the author

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atan, A. Multiparametric prostatic MRI should not be the only method to decide re-biopsy in the patients who had a negative prostatic biopsy. Int Urol Nephrol 51, 1781–1782 (2019). https://doi.org/10.1007/s11255-019-02227-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02227-w

Search

Navigation